Rho kinase inhibition: A new approach for treating diabetic nephropathy?

被引：27

作者：

Bach, Leon A. ^{[1
]}

机构：

[1] Alfred Hosp, Dept Endocrinol & Diabet, Melbourne, Vic 3004, Australia

来源：

DIABETES | 2008年 / 57卷 / 03期

关键词：

D O I：

10.2337/db07-1768

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：532 / 533

页数：2

相关论文

共 12 条

[1]

Targeting Rho and Rho-kinase in the treatment of cardiovascular disease [J].

Budzyn, K ;

Marley, PD ;

Sobey, CG .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (02) :97-104

[2]

HMG-CoA reductase inhibitors and the kidney [J].

Campese, V. M. ;

Park, J. .

KIDNEY INTERNATIONAL, 2007, 71 (12) :1215-1222

[3]

3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy [J].

Danesh, FR ;

Sadeghi, MM ;

Amro, N ;

Philips, C ;

Zeng, LX ;

Lin, S ;

Sahai, A ;

Kanwar, YS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8301-8305

[4]

Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].

Davies, SP ;

Reddy, H ;

Caivano, M ;

Cohen, P .

BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105

[5]

The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats [J].

Gojo, Atsushi ;

Utsunomiya, Kazunori ;

Taniguchi, Kanta ;

Yokota, Tamotsu ;

Ishizawa, Shoh ;

Kanazawa, Yasushi ;

Kurata, Hideaki ;

Tajima, Naoko .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 568 (1-3) :242-247

[6]

HAYASHI K, 2006, J PHARM SCI, V29, P100

[7]

A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats [J].

Kikuchi, Yuichi ;

Yamada, Muneharu ;

Imakfire, Toshihiko ;

Kushiyama, Taketoshi ;

Higashi, Keishi ;

Hyodo, Naomi ;

Yamamoto, Kojiro ;

Oda, Takashi ;

Suzuki, Shigenobu ;

Miura, Soichiro .

JOURNAL OF ENDOCRINOLOGY, 2007, 192 (03) :595-603

[8]

Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control [J].

Kolavennu, Vasantha ;

Zeng, Lixia ;

Peng, Hui ;

Wang, Yin ;

Danesh, Farhad R. .

DIABETES, 2008, 57 (03) :714-723

[9]

Increased RhoA translocation in renal cortex of diabetic rats [J].

Massey, AR ;

Miao, LY ;

Smith, BN ;

Liu, JJ ;

Kusaka, I ;

Zhang, JH ;

Tang, JP .

LIFE SCIENCES, 2003, 72 (26) :2943-2952

[10]

Signaling: Focus on Rho in renal disease [J].

Sharpe, CC ;

Hendry, BM .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (01) :261-264